| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.5 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |